Skip to main content
Caplight Logo









QuantuMDx

QuantuMDx

Private
Newcastle upon Tyne, EnglandHealthcare & Life Scienceshttps://quantumdx.com

Last Round

VC Round

Nov 8, 2021

Total Funding Raised

$16.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

QuantuMDx operates in Healthcare & Life Sciences and is based in Newcastle upon Tyne, England. Its latest recorded funding round was a VC Round in November 2021.

QuantuMDx is a British medical technology company founded in 2008 that specializes in developing molecular diagnostic solutions for point-of-care testing. The company's mission is to make high-quality, rapid diagnostics accessible and affordable globally, particularly in resource-limited settings. Its flagship product, the Q-POC™, is a portable, battery-operated PCR system that provides rapid, actionable results in approximately 30-35 minutes. QuantuMDx is a privately held, venture-backed company that has progressed to a Series D funding stage. The company is headquartered in Newcastle upon Tyne, UK, and has global partnerships across multiple continents.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

QuantuMDx Comparables

Compare QuantuMDx with similar companies based on industry and business-model similarity.

QuantuMDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Credo Diagnostics Biomedical
87%
Nuclein
86%
binx health
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

QuantuMDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 8, 2021
DebtMar 24, 2021
GrantOct 17, 2013
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jonathan O'Halloran

Chief Executive Officer

Executive Team

Martin Walton

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

QuantuMDx Investors

Notable investors and investment history

QuantuMDx investors
InvestorRounds
British Business BankDebt
Innovate UKGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 139% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

QuantuMDx Filings

Explore SEC and related filing metadata, where available.

QuantuMDx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about QuantuMDx's valuation, stock price, and market status.

Is QuantuMDx a public or private company?

QuantuMDx is a private company.

What is the current stock price of QuantuMDx?

QuantuMDx is a private company, so its shares have no public market price. Caplight tracks QuantuMDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is QuantuMDx worth (valuation)?

Valuation information for QuantuMDx is not publicly available.

Can I buy QuantuMDx stock?

QuantuMDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was QuantuMDx's last funding round?

QuantuMDx's most recent funding round was VC Round on November 8, 2021.

Who are the main investors in QuantuMDx?

Key investors in QuantuMDx include British Business Bank, Innovate UK.

Will QuantuMDx IPO soon?

No public IPO plans have been announced for QuantuMDx.

How can I track QuantuMDx secondary market activity?

Caplight tracks bids, offers, and trades in QuantuMDx's shares on secondary markets.

Firmographic Details

HeadquartersNewcastle upon Tyne, England
Employee Range52
Year Founded2008
Last FundingNov 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?